Australian Dairy Nutritionals (ASX:AHF) Cuts FY26 Loss Amid Nutritional Powder Sales Growth

Aditi Sarkar

06 November 2026 10:34 PM AEDT

Australian Dairy Nutritionals (ASX:AHF) Cuts FY26 Loss Amid Nutritional Powder Sales Growth

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

Australian Dairy Nutritionals reduced its FY26 net loss 47% to AUD 2.79 million, compared with AUD 5.26 million in FY25.
Annual Revenue increased approximately 42% during FY26 as nutritional powder sales supported continued growth in the company’s consumer products business.
Quarterly revenue rose from AUD 1.4 million in the second quarter to AUD 2.6 million in the fourth quarter, overall.
The company ended its joint venture with Wellnex Life in June 2026, refocusing attention on its Future nutritional products brand.

Australian Dairy Nutritionals Group (ASX:AHF) is a vertically integrated Australian dairy company based in Camperdown, Victoria. The company owns organic and A2 protein dairy farms in Victoria and a processing facility, supplying premium dairy products and nutritional powder products (including infant formula under the Future brand) to domestic and international markets, with a primary growth focus on the Chinese infant formula and nutritional supplement market. FY26 (year ended 30 June 2026) Annual Report and Appendix 4E were released on 27 August 2026.

Revenue Growth and Quarterly Trajectory

Australian Dairy Nutritionals delivered strong top-line growth through FY26. Q1 FY26 (July–September 2025) revenue was $1.9 million, with nutritional powder sales contributing $1.3 million, partly driven by China sales momentum. Q2 FY26 (October–December 2025) revenue was $1.4 million, with nutritional powder sales up 152% on Q2 FY25. Q4 FY26 (April–June 2026) revenue jumped to $2.6 million, described by management as driven by a "substantial increase in nutritional powder sales." For H1 FY26, total revenue was $3.198 million, up 14% on H1 FY25. Full-year FY26 revenue grew approximately 42% based on the quarterly trajectory and stockanalysis.com data showing trailing twelve-month revenue of approximately $7.2 million. The company achieved record production during Q1 FY26 and planned further distribution expansion.

Net Loss Improvement and China Strategy

Australian Dairy Nutritionals' primary strategic focus is growing the Future infant formula and nutritional powder Brand in China. The company targeted expansion to 1,000 stores in China by FY26 year-end, up from a smaller store network at the start of the year. The Chinese infant formula market is large and premium, particularly for Australian-sourced, organic-certified, and A2 protein products. The H1 FY26 net loss improvement of 40% (to $1.22 million) and the full-year net loss improvement of 47% (to $2.79 million) reflect both higher revenue and cost management, though the company remains pre-profitability. Cash at H2 FY26 close was $1.16 million (net assets), with management confident in the ability to raise additional Capital to support operations and growth plans.

JV Termination and Business Focus

On 1 June 2026, the joint venture between Australian Dairy Nutritionals and Wellnex Life Limited (ASX:WNX) was formally terminated. The JV had been formed to explore complementary opportunities between AHF's dairy and nutritional product capabilities and Wellnex Life's consumer health distribution networks. The termination allows AHF to focus capital and management resources on its core vertically integrated dairy farming, processing, and nutritional powder export business — particularly the Future brand's China expansion — without the complexity of a joint venture structure. The company's FY26 Appendix 4E notes the JV termination as a loss or gain of control over other entities event.

Stock Price Information

Shares in Australian Dairy Nutritionals Group (ASX:AHF) traded at approximately $0.017 at the Q4 FY26 trading update (31 July 2026). The stock has seen significant Volatility during FY26, reflecting both the company's growth trajectory and its pre-profitability status with ongoing capital needs. As of 6 November 2026, AHF shares were trading on the ASX. Investors should monitor ASX announcements at www.asx.com.au and Investor relations at www.adnl.com.au for the latest company disclosures and capital plans.

FAQs

Q: What is the Future brand and where is it sold?

A: Future is Australian Dairy Nutritionals' infant formula and nutritional powder brand, manufactured at the company's processing facility in Camperdown, Victoria, using milk from its organic and A2 protein dairy farms. The brand is primarily distributed in China through retail channels (brick-and-mortar stores), with management targeting 1,000 stores by the end of FY26. The Future brand positions itself as a premium Australian-origin organic or A2 infant formula, targeting the significant Chinese consumer segment that values international, particularly Australian and New Zealand-sourced, infant nutrition products for safety, quality, and nutritional differentiation reasons.

Q: What does vertically integrated mean for Australian Dairy Nutritionals?

A: Vertically integrated means Australian Dairy Nutritionals controls the entire supply chain from farm to finished product. The company owns its own dairy farms in Victoria, producing organic and A2 protein milk, which is then processed at its own Camperdown facility into nutritional powders, infant formula, and other dairy products. This vertical integration theoretically provides quality control from paddock to package, margin capture at each stage of the supply chain (rather than buying ingredients from third parties), and differentiated product claims such as "farm-to-table" traceability that are valued by premium consumers in China and other export markets. The trade-off is higher capital requirements and operational complexity compared to a pure brand or distribution business.

Q: Why is AHF still raising capital despite revenue growth?

A: Australian Dairy Nutritionals is growing revenue strongly (approximately 42% in FY26) but remains unprofitable — it reported a $2.79 million net loss in FY26 despite significant improvement. At this stage of growth, the company requires capital for: working capital to fund inventory and receivables as sales volumes grow; marketing and distribution investment to continue expanding the Future brand's China store network; and farm and processing facility maintenance and improvement. Cash at year-end was $1.16 million, which is modest relative to quarterly operating cash outflows, so the company regularly raises equity from investors to fund the gap between operating cash outflows and revenue collections. As revenue continues to grow and losses narrow, the company expects to reach cash flow breakeven and reduce its reliance on external capital.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.